Cassava Sciences Reports No Evidence of Data Manipulation in 2012 Article
“Cassava Sciences Inc. shares were halted at $56.66 in early trade Thursday after the company said it has been informed by the Journal of Neuroscience that there is no evidence of data manipulation in an article it published in July 2012 describing a new approach to treating Alzheimer's disease.”